Skip to: Content
Skip to: Site Navigation
Skip to: Search


Medicating the Mind track this thread

Started by K Thompson; Last updated by K Thompson | View history

Medicating the Mind

Advancements in psychiatry are coming thick and fast—and are more in demand than ever, as diagnosis rates for mental illnesses continue to rise.

As public awareness of mental disease is on the rise, so are diagnoses ranging from autism to bulimia to schizophrenia. Universities and drug companies alike are putting their best men and women on the job to develop better diagnoses and treatments while expanding our knowledge of the mind, but we may still just be scratching the surface of those little grey cells.

Stories

Stories 1 - 20 of 68

  • November 2008
    • Warning Labels Can Be Hazardous to Your Health

      Warning Labels Can Be Hazardous to Your Health

      (Newser) - Ignorance truly is bliss when it comes to prescription drugs. The side effects listed on warning labels have a self-fulfilling quality, researchers tell the Wall Street Journal . People sensitive to this "nocebo effect" should think twice before reading that their pills can cause nausea, vomiting, irritability, or difficulty concentrating. For many, merely knowing about those symptoms can prompt them. More »

    • Study Paves Way for 'Entrepreneur Pill'

      Study Paves Way for 'Entrepreneur Pill'

      (Newser) - A study that links entrepreneurial success to risky decision-making, a trait less prevalent among buttoned-up business managers, has scientists pondering whether a pill could boost enterprising behavior. Riskiness is associated with the hormone dopamine, which could inject chutzpah into hesitant managers, the Telegraph reports. Critics doubt chemicals are solely responsible, pointing out that older entrepreneurs—whose dopamine is depleting—remain risk-takers. More »

  • October 2008
    • Electric Therapy Can Relieve Depression

      Electric Therapy Can Relieve Depression

      (Newser) - People with major depression that doesn't respond to medication may get relief from a therapy that uses magnetic pulses to stimulate the cortex, the Wall Street Journal reports. In a clinical trial, transcranial magnetic stimulation worked in about a quarter of patients—about twice the success rate of patients on a placebo. More »

    • Suicide Rate Soars for Middle-Aged

      Suicide Rate Soars for Middle-Aged

      (Newser) - A sharp rise in the number of middle-aged white people taking their own lives has driven up the US suicide rate by nearly 5% since 1999, the Los Angeles Times reports. Experts are baffled by the nearly 16% hike in this group, but speculate that prescription drug abuse, a drop in the use of hormone replacement therapy by menopausal women, or post-9/11 stress could be the cause—as could widespread Boomer disappointment. More »

  • September 2008
    • Heart Disease Linked to Depression

      Heart Disease Linked to Depression

      (Newser) - People suffering from heart disease are three times more likely to be depressed, according to a study that found young women particularly at risk. Researchers urged doctors to monitor heart patients for depression, reports the San Francisco Chronicle , noting that it not only affects quality of life but can adversely a patient's prognosis. Some 80 million Americans suffer from heart disease. More »

    • Autism-Reversing Drugs Show Promise

      Autism-Reversing Drugs Show Promise

      (Newser) - MIT scientists have discovered one of the mechanisms of Fragile X Syndrome, one cause of autism, and are developing drugs to treat it, NPR reports. The disorder, triggered by a genetic mutation, interferes with the normal links between brain cells, making those networks something like a car without a brakes. The new drugs limit acceleration, and have been successful in mice. More »

    • Gender Influences Effectiveness of Antidepressants

      Gender Influences Effectiveness of Antidepressants

      (Newser) - The results of the largest-ever federal study of depression are in, and the link between gender and treatment is clearer than ever before, Newsweek reports. Men and premenopausal women respond differently to different formulations of drugs, suggesting the strong influence of estrogen and reinforcing the gap between two commonly prescribed classes of drugs: tricyclics, which are more effective in men, and SSRIs, to which women respond more readily. More »

    • Hallucinogenic Plant's High May Knock Medical Use Down

      Hallucinogenic Plant's High May Knock Medical Use Down

      (Newser) - A hallucinogenic herb pharmacologists believe holds great promise for pain relief and mental health treatment is facing tough restrictions thanks to thrill-seekers, the New York Times reports. Users of the highly potent psychedelic Salvia divinorum—dubbed "Magic Mint" by users—have been posting videos of their trips on YouTube, which often become Exhibit A when states seek to ban it. More »

    • Bipolar Risk Rises With Father's Age

      Bipolar Risk Rises With Father's Age

      (Newser) - Children born to fathers older than 30 have an 11% higher chance of developing bipolar disorder than kids with younger dads, and the risk increases with the father’s age, new research reveals. The rate climbs to 37% of offspring of fathers aged 55, Reuters reports, compared to the overall incidence of the disorder of 1% to 3% in all adults. More »

  • August 2008
    • Colleges Face Suicide Crisis

      Colleges Face Suicide Crisis

      (Newser) - More than half the students at 70 US colleges have contemplated suicide, a startling new study has found. Surveys revealed that 55% once thought of taking their own lives, 18% seriously considered it and 8% actually tried, reports USA Today . Broken romances, school-related problems, and emotional and physical pain were most often cited as the reasons. More »

    • Drugs Shrinking Psychiatrists' Talk Time: Study

      Drugs Shrinking Psychiatrists' Talk Time: Study

      (Newser) - Psychiatry is increasingly focused on prescribing drugs and less on psychotherapy, a study published in the Archives of General Psychology finds. A reluctance by insurance firms to pay for therapy is one factor, HealthDay reports, along with the wide variety of drugs now available to treat various conditions. More »

  • July 2008
    • Missing DNA Sheds Light on Roots of Schizophrenia

      Missing DNA Sheds Light on Roots of Schizophrenia

      (Newser) - Missing chunks of DNA increase a child's chance of developing schizophrenia by up to 10 times, say to two major international studies. Scientists are calling the data from more than 3,000 schizophrenia patients a huge step toward finding the genetic source of the disease, which could ultimately help doctors improve diagnosis and treatment, the Boston Globe reports. More »

    • 'Pre-Dementia' on the Rise

      'Pre-Dementia' on the Rise

      (Newser) - Almost a million Americans each year develop a mild form of memory loss that is often a precursor to Alzheimer's, according to new research. Mild Cognitive Impairment—more serious than normal "senior moments"—was found to be more common in men, the Los Angeles Times reports. Doctors warn that a crisis is looming as the Baby Boom generation ages. More »